Mirae Asset Global Etfs Holdings Ltd. Roivant Sciences Ltd. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 91,444 shares of ROIV stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,444Holding current value
$1.06 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
524MCall Options Held
1.3MPut Options Held
1.09M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$831 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$805 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$777 Million72.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$412 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.2B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...